Inventor · disambiguated record
Matthew G. Laporte
Also filed as: LAPORTE MATTHEW G
33 granted patents·11 pending applications·369 citations·filing 2003–2022
97Inventor score
Files withCONDON STEPHEN M13TETRALOGIC PHARM CORP11UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION8TETRALOGIC BIRINAPANT UK LTD5MEDIVIR AB3
Top patents by PatentIndex Score
44 records- 0196US7517906B2Dimeric IAP inhibitorsTETRALOGIC PHARMACEUTICALS COR·Filed 2006·Granted Apr 14, 2009·98 cites·34 claims
- 0295US8283372B22-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimeticCONDON STEPHEN M·Filed 2010·Granted Oct 9, 2012·25 cites·4 claims
- 0395US8022230B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2009·Granted Sep 20, 2011·25 cites·1 claims
- 0495US7456209B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2005·Granted Nov 25, 2008·35 cites·16 claims
- 0594US8603816B2SMAC mimeticCONDON STEPHEN M·Filed 2012·Granted Dec 10, 2013·15 cites·8 claims
- 0693US8986993B2SMAC mimetic for treating myelodysplastic syndromesTETRALOGIC PHARM CORP·Filed 2013·Granted Mar 24, 2015·12 cites·4 claims
- 0793US7968590B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2008·Granted Jun 28, 2011·19 cites·20 claims
- 0892US7985735B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2007·Granted Jul 26, 2011·19 cites·40 claims
- 0991US8822525B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2013·Granted Sep 2, 2014·12 cites·21 claims
- 1091US8415486B2IAP inhibitorsCONDON STEPHEN M·Filed 2010·Granted Apr 9, 2013·23 cites·33 claims
- 1191US8143426B2IAP inhibitorsCONDON STEPHEN M·Filed 2007·Granted Mar 27, 2012·13 cites·42 claims
- 1290US10314881B2SMAC mimeticTETRALOGIC BIRINAPANT UK LTD·Filed 2018·Granted Jun 11, 2019·5 cites·9 claims
- 1390US8802716B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2013·Granted Aug 12, 2014·9 cites·26 claims
- 1490US8497297B2Dimeric IAP inhibitorsCONDON STEPHEN M·Filed 2011·Granted Jul 30, 2013·17 cites·32 claims
- 1589US10596220B2SMAC mimeticMEDIVIR AB·Filed 2019·Granted Mar 24, 2020·3 cites·13 claims
- 1689US10034912B2SMAC MimeticTETRALOGIC BIRINAPANT UK LTD·Filed 2016·Granted Jul 31, 2018·5 cites·17 claims
- 1789US9187490B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2014·Granted Nov 17, 2015·8 cites·5 claims
- 1887US8399683B2IAP inhibitorsCONDON STEPHEN M·Filed 2009·Granted Mar 19, 2013·10 cites·34 claims
- 1986US11351221B2SMAC mimeticMEDIVIR AB·Filed 2020·Granted Jun 7, 2022·1 cites·15 claims
- 2086US8481495B2IAP inhibitorsCONDON STEPHEN M·Filed 2010·Granted Jul 9, 2013·9 cites·28 claims
- 2184US11951147B2SMAC mimeticMEDIVIR AB·Filed 2022·Granted Apr 9, 2024·0 cites·17 claims
- 2282US11214560B2Modulators of P97 AAA ATPase activityUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2018·Granted Jan 4, 2022·3 cites·22 claims
- 2380US10894782B2Modulators of P97 AAA ATPase activityUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2017·Granted Jan 19, 2021·1 cites·26 claims
- 2479US9394249B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2014·Granted Jul 19, 2016·2 cites·15 claims
- 2567US11773075B2Modulators of p97 AAA ATPase activityUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2021·Granted Oct 3, 2023·0 cites·22 claims
- 2662US2021070732A1Modulators of p97 aaa atpase activityUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2020·Application pending·0 cites
- 2761US9920093B2Dimeric IAP inhibitorsTETRALOGIC BIRINAPANT UK LTD·Filed 2016·Granted Mar 20, 2018·0 cites·21 claims
- 2861US9840464B2IAP binding compoundsTETRALOGIC BIRINAPANT UK LTD·Filed 2016·Granted Dec 12, 2017·0 cites·20 claims
- 2959US11247985B2Phenyl indole allosteric inhibitors of P97 ATPaseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Granted Feb 15, 2022·0 cites·8 claims
- 3059US11111253B26-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activityUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Granted Sep 7, 2021·0 cites·15 claims
- 3159US2015158908A1SMAC Mimetic for Treating Myelodysplastic SyndromesTETRALOGIC PHARM CORP·Filed 2015·Application pending·0 cites
- 3258US2012115922A1Smac mimetecCONDON STEPHEN M·Filed 2010·Application pending·0 cites
- 3358US2016052965A1Dimeric IAP InhibitorsTETRALOGIC BIRINAPANT UK LTD·Filed 2015·Application pending·0 cites
- 3458US2011294827A1Iap binding compoundsCONDON STEPHEN M·Filed 2011·Application pending·0 cites
- 3554US2012157390A1IAP InhibitorsCONDON STEPHEN M·Filed 2012·Application pending·0 cites
- 3653US10633370B2Phenyl indole allosteric inhibitors of p97 ATPaseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Apr 28, 2020·0 cites·11 claims
- 3750US2011288116A1Iap inhibitorsCONDON STEPHEN M·Filed 2009·Application pending·0 cites
- 3850US2013274278A1Iap inhibitorsTETRALOGIC PHARM CORP·Filed 2013·Application pending·0 cites
- 3949US2024051931A1Hdac inhibitorsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2021·Application pending·0 cites
- 4047US12486231B2Targeted nitroxide compounds and their use in treating ferroptosis-related diseasesUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Granted Dec 2, 2025·0 cites·16 claims
- 4146US2011305777A1Dimeric iap antagonistsCONDON STEPHEN M·Filed 2011·Application pending·0 cites
- 4243US10618914B26-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-B][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activityUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Apr 14, 2020·0 cites·18 claims
- 4342US7217730B2Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virusVIROPHARMA INC·Filed 2003·Granted May 15, 2007·0 cites·62 claims
- 4441US2007219212A1Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or DiseaseCONDON STEPHEN M·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew G. Laporte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →